新晨科技(300542.SZ)獲一項發明專利證書
格隆匯3月3日丨新晨科技(300542.SZ)公佈,公司於近日取得由國家知識產權局頒發的《發明專利證書》。
本發明提供一種便攜式防盜IC卡讀寫裝置及讀寫方法,它通過在IC卡讀寫裝置處於的不同的狀態進行電流計算值的檢測與監控,根據預設的門限值,告警異常電流計算值,以防範通過硬件盜取裝置嵌入IC卡讀寫裝置攻擊IC交易過程盜取IC卡賬户資金的風險。本發明具有結構簡單、易於擴展的優點,大大提高了便攜式IC卡讀寫裝置的使用安全性。
上述發明專利證書的取得不會直接對公司生產經營產生重大影響,但有利於充分發揮公司自主知識產權優勢,對公司開拓市場、提升品牌影響力產生積極的影響,保持公司技術的領先性,提升公司的核心競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.